View:
Download DOC
Download PDF
SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940 		 
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
McGill Iain
(Last) (First) (Middle)
C/O JAZZ PHARMACEUTICALS PLC
CONNAUGHT HOUSE, 1 BURLINGTON RD, FL. 4
(Street)
DUBLIN 4 L2
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
07/31/2014 		3. Issuer Name and Ticker or Trading Symbol
Jazz Pharmaceuticals plc [ JAZZ ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Head of EUSA Int'l & SVP
 5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares 27,553(1) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Nonstatutory Stock Option (right to buy) (2) 08/08/2022 Ordinary Shares 22,500 46.83 D
Nonstatutory Stock Option (right to buy) (3) 03/04/2023 Ordinary Shares 8,500 59.13 D
Nonstatutory Stock Option (right to buy) (4) 02/26/2024 Ordinary Shares 11,500 166.62 D
Explanation of Responses:
1. Including 25,250 restricted stock units ("RSUs") granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each RSU represents a contingent right to receive one ordinary share upon the vesting of the unit. Of the 25,250 RSUs, 15,000 RSUs vest in three equal annual installments from August 9, 2014 to August 9, 2016, 4,500 RSUs vest in three equal annual installments from March 5, 2015 to March 5, 2017, and 5,750 RSUs vest in four equall annual installments from February 27, 2015 to February 27, 2018.
2. This option was granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to this option vested with respect to 1,666 shares and vest with respect to 20,834 shares in equal monthly installments from August 9, 2014 to August 9, 2016.
3. This option was granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to this option vested with respect to 750 shares and vest with respect to 7,750 shares in equal monthly installments from September 5, 2014 to March 5, 2017.
4. This option was granted pursuant to the Issuer's 2011 Equity Incentive Plan. 1/4th of the ordinary shares subject to this option vest on February 27, 2015 and the remainder vest in equal monthly installments from March 27, 2015 to February 27, 2018.
Remarks:
/s/ Larissa Schwartz as attorney in fact for Iain McGill 08/07/2014
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
POWER OF ATTORNEY



 Know all by these presents, that the undersigned hereby constitutes and appoints each of

SUZANNE SAWOCHKA HOOPER, VALERIE PIERCE, SOFIA LOU and LARISSA SCHWARTZ signing

individually, the undersigned's true and lawful attorneys-in fact and agents to:



       1) execute for and on behalf of the undersigned (a) Forms 3, 4 and 5 in accordance with

Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") and the rules

thereunder and (b) Forms 144 in accordance with Rule 144 promulgated under the Securities Act of

1933, as amended, as such Rule may be amended from time to time (or any successor rule) ("Rule

144");



       2) do and perform any and all acts for and on behalf of the undersigned that may be

necessary or desirable to complete and execute such Forms 3, 4, 5 or 144 (collectively, the "Forms"),

complete and execute any amendment or amendments thereto, and timely file such Forms or

amendments with the U.S. Securities and Exchange Commission and any stock exchange or similar

authority; and



       3) take any other action of any nature whatsoever in connection with the foregoing which, in

the opinion of such attorney-in-fact, may be of benefit, in the best interest of, or legally required by, the

undersigned, including but not limited to executing and delivering for and on behalf of the undersigned

any seller's representation letter that may be required to be submitted to any broker effecting any sale of

securities issued by Jazz Pharmaceuticals plc (the "Company") for the account of the undersigned, it

being understood that the documents executed by such attorney-in-fact on behalf of the undersigned

pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as

such attorney-in-fact may approve in such attorney-in-fact's discretion.



 The undersigned hereby grants to each such attorney-in-fact full power and authority to do and

perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise

of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned

might or could do if personally present, with full power of substitution or revocation, hereby ratifying and

confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully

do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The

undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request

of the undersigned, are not assuming, nor is the Company or any of its affiliates, assuming, any of the

undersigned's responsibilities to comply with (a) Section 16 of the Exchange Act and (b) all of the

applicable conditions of the Rule 144 safe harbor with respect to a sale of securities issued by the

Company.



 This Power of Attorney shall remain in full force and effect until the earliest to occur of (a) the

undersigned is no longer required to file any Forms with respect to the undersigned's holdings of and

transactions in securities issued by the Company, (b) revocation by the undersigned in a signed writing

delivered to the foregoing attorneys-in-fact or (c) as to any attorney-in-fact individually, until such

attorney-in-fact shall no longer be employed by the Company or an affiliate of the Company.



       IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of

this 31st day of July 2014.

       /s/ Iain McGill

       IAIN MCGILL